European shares reached record highs due to strong performances in the chemicals and healthcare sectors. Influential moves included EMS Chemie's upgrade by UBS and AstraZeneca's acquisition. Meanwhile, EU-Mercosur trade impacts and challenges for luxury brands amid Saks Global's bankruptcy added complexity to the market landscape.
European Stocks Hit New Highs Amid Chemical and Healthcare Sector Surge
